Sort
82,697 grants matching “vaccine development”
Novel Therapeutics for Neurotropic Alphaviruses
$927,665David J Miller · University Of Michigan At Ann Arbor · R01 · FY2014 · AI
Novel Therapeutics for Neurotropic Alphaviruses
$927,665David J Miller · University Of Michigan At Ann Arbor · R01 · FY2012 · AI
Non-Human Primate Core
$927,631Ivona Pandrea · University Of Pennsylvania · P01 · FY2012 · AI
Malaria Drug Resistance and Disease Virulence
$927,613Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Vascular macrophages and T cells in atherosclerosis
$927,585Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2019 · HL
Structural vaccinology for infectious diseases
$927,506Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$927,069Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2021 · AI
DEVELOPMENT OF AN ATTENUATED VACCINE FOR THE PREVENTION OF LYME DISEASE
$927,000University Of Toledo · · FY2021 · Defense Health Agency
High-throughput identification of antibody features for sequence-based epitope prediction
$926,998Nicholas C. Wu · University Of Illinois At Urbana-Champaign · DP2 · FY2024 · AT
Preclinical Development of a Novel and Powerful Immunotherapeutic
$926,922Susan Dana Jones · Immurx Llc · R44 · FY2011 · AI
Inducing HIV-1 NAb Breadth by Native Trimer Prime-Boost Vaccination
$926,870James M Binley · San Diego Biomedical Research Institute · R01 · FY2024 · AI
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination
$926,831Alessandro Sette · La Jolla Institute For Immunology · N01 · FY2020 · AI
Pediatric AIDS Clinical Trials Unit
$926,698Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2006 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$926,653Marco Colonna · Washington University · U01 · FY2016 · AI
Project 3 - Flavivirus - UTMB
$926,569Pei-Yong Shi · University Of Alabama At Birmingham · U19 · FY2021 · AI
Live, recombinant newcastle disease virus-based vaccine against high pri pathoge
$926,528Peter Palese · Columbia University Health Sciences · U54 · FY2010 · AI
The mucosal immune system: effects of aging and chronic antigenic stimulation
$926,520Rita Brickman Effros · University Of California Los Angeles · R01 · FY2013 · AG
Investigating the Protective Efficacy of SIV/HIV T and B cell Immunity Induced by RNA Replicons
$926,410Gaurav Das Gaiha · Massachusetts General Hospital · R01 · FY2023 · AI
A Therapeutic Vaccine for Chronic Hepatitis B
$926,325David R. Milich · Vlp Biotech, Inc. · R44 · FY2012 · AI
Novel Immunoprophylaxes against Clostridium difficile Infection
$926,180Hanping Feng · University Of Maryland Baltimore · U19 · FY2017 · AI
Vaccine Development for Oral Carcinoma
$926,163University Of Pittsburgh At Pittsburgh · P01 · FY2002 · DE
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$925,915Kathleen Powis · Massachusetts General Hospital · R01 · FY2022 · AI
Cytokine Gene Therapy of Cancer - Preclinical Studies
$925,900Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Papillomavirus Virion Proteins and Vaccines
$925,516Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
$925,466Robert E Braun · Jackson Laboratory · UM1 · FY2020 · OD